acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)

C173H234F36N34O36 — CID 159712247

About acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)

acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid) (PubChem CID 159712247) has the molecular formula C173H234F36N34O36 and a molecular weight of 4049.90 g/mol. Its IUPAC name is acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid).

Molecular Properties

• Compound Name: acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)
• PubChem CID: 159712247
• Molecular Formula: C173H234F36N34O36
• Molecular Weight: 4049.90 g/mol
• Exact Mass: 4047.70
• IUPAC Name: acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)
• SMILES: CC(=O)O.CC(=O)O.CCN(CC)c1cnc2c(c1)c(C(=O)NC1CCCCC1)nn2C.CN1C2CCC1CC(Nc1ccc3c(C(=O)CC4CCCCC4)nn(C)c3n1)C2.C[C@@H](COCc1nn(C)c2nc(N3CCCCCC3)ccc12)CN1CCCC1.C[C@H](COCc1nn(C)c2nc(N3CCCCCC3)ccc12)CN1CCCC1.Cn1nc(C(=O)CC2CCCCC2)c2ccc(N3CCCNCC3)nc21.Cn1nc(C(=O)NC2CCCCC2)c2cc(-c3ccoc3)cnc21.Cn1nc(COCCCCN2CCCC2)c2ccc(N3CCCCCC3)nc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
• InChI: InChI=1S/C23H33N5O.3C22H35N5O.C20H29N5O.C18H27N5O.C18H20N4O2.12C2HF3O2.2C2H4O2/c1-27-17-8-9-18(27)14-16(13-17)24-21-11-10-19-22(26-28(2)23(19)25-21)20(29)12-15-6-4-3-5-7-15;2*1-18(15-26-11-7-8-12-26)16-28-17-20-19-9-10-21(23-22(19)25(2)24-20)27-13-5-3-4-6-14-27;1-25-22-19(10-11-21(23-22)27-15-4-2-3-5-16-27)20(24-25)18-28-17-9-8-14-26-12-6-7-13-26;1-24-20-16(8-9-18(22-20)25-12-5-10-21-11-13-25)19(23-24)17(26)14-15-6-3-2-4-7-15;1-4-23(5-2)14-11-15-16(21-22(3)17(15)19-12-14)18(24)20-13-9-7-6-8-10-13;1-22-17-15(9-13(10-19-17)12-7-8-24-11-12)16(21-22)18(23)20-14-5-3-2-4-6-14;12*3-2(4,5)1(6)7;2*1-2(3)4/h10-11,15-18H,3-9,12-14H2,1-2H3,(H,24,25);2*9-10,18H,3-8,11-17H2,1-2H3;10-11H,2-9,12-18H2,1H3;8-9,15,21H,2-7,10-14H2,1H3;11-13H,4-10H2,1-3H3,(H,20,24);7-11,14H,2-6H2,1H3,(H,20,23);12*(H,6,7);2*1H3,(H,3,4)/t;2*18-;;;;;;;;;;;;;;;;;;/m.10................../s1
• InChIKey: XZVBTIPCSLBOAI-YYHJWAEDSA-N
• XLogP: 31.96
• TPSA: 923.56 Ų
• H-Bond Donors: 18
• H-Bond Acceptors: 54
• Rotatable Bonds: 39
• Heavy Atoms: 279
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	4049.90
LogP ≤ 5	31.96
H-Bond Donors ≤ 5	18
H-Bond Acceptors ≤ 10	54

Frequently Asked Questions

What is the IUPAC name of acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)?

The IUPAC name of acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid) (CID 159712247) is acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid).

What is the SMILES notation for acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)?

The canonical SMILES for acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid) is CC(=O)O.CC(=O)O.CCN(CC)c1cnc2c(c1)c(C(=O)NC1CCCCC1)nn2C.CN1C2CCC1CC(Nc1ccc3c(C(=O)CC4CCCCC4)nn(C)c3n1)C2.C[C@@H](COCc1nn(C)c2nc(N3CCCCCC3)ccc12)CN1CCCC1.C[C@H](COCc1nn(C)c2nc(N3CCCCCC3)ccc12)CN1CCCC1.Cn1nc(C(=O)CC2CCCCC2)c2ccc(N3CCCNCC3)nc21.Cn1nc(C(=O)NC2CCCCC2)c2cc(-c3ccoc3)cnc21.Cn1nc(COCCCCN2CCCC2)c2ccc(N3CCCCCC3)nc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.

What is the InChIKey of acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)?

The InChIKey is XZVBTIPCSLBOAI-YYHJWAEDSA-N. The full InChI is InChI=1S/C23H33N5O.3C22H35N5O.C20H29N5O.C18H27N5O.C18H20N4O2.12C2HF3O2.2C2H4O2/c1-27-17-8-9-18(27)14-16(13-17)24-21-11-10-19-22(26-28(2)23(19)25-21)20(29)12-15-6-4-3-5-7-15;2*1-18(15-26-11-7-8-12-26)16-28-17-20-19-9-10-21(23-22(19)25(2)24-20)27-13-5-3-4-6-14-27;1-25-22-19(10-11-21(23-22)27-15-4-2-3-5-16-27)20(24-25)18-28-17-9-8-14-26-12-6-7-13-26;1-24-20-16(8-9-18(22-20)25-12-5-10-21-11-13-25)19(23-24)17(26)14-15-6-3-2-4-7-15;1-4-23(5-2)14-11-15-16(21-22(3)17(15)19-12-14)18(24)20-13-9-7-6-8-10-13;1-22-17-15(9-13(10-19-17)12-7-8-24-11-12)16(21-22)18(23)20-14-5-3-2-4-6-14;12*3-2(4,5)1(6)7;2*1-2(3)4/h10-11,15-18H,3-9,12-14H2,1-2H3,(H,24,25);2*9-10,18H,3-8,11-17H2,1-2H3;10-11H,2-9,12-18H2,1H3;8-9,15,21H,2-7,10-14H2,1H3;11-13H,4-10H2,1-3H3,(H,20,24);7-11,14H,2-6H2,1H3,(H,20,23);12*(H,6,7);2*1H3,(H,3,4)/t;2*18-;;;;;;;;;;;;;;;;;;/m.10................../s1.

What are the key properties of acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid)?

acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid) has a molecular weight of 4049.90 g/mol, XLogP of 31.96, 39 rotatable bonds, 18 hydrogen bond donors, and 54 hydrogen bond acceptors.

Where does this data come from?

All data for acetic acid;6-(azepan-1-yl)-1-methyl-3-[[(2R)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-[[(2S)-2-methyl-3-pyrrolidin-1-ylpropoxy]methyl]pyrazolo[3,4-b]pyridine;6-(azepan-1-yl)-1-methyl-3-(4-pyrrolidin-1-ylbutoxymethyl)pyrazolo[3,4-b]pyridine;2-cyclohexyl-1-[6-(1,4-diazepan-1-yl)-1-methylpyrazolo[5,4-b]pyridin-3-yl]ethanone;N-cyclohexyl-5-(diethylamino)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;N-cyclohexyl-5-(furan-3-yl)-1-methylpyrazolo[5,4-b]pyridine-3-carboxamide;2-cyclohexyl-1-[1-methyl-6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyrazolo[5,4-b]pyridin-3-yl]ethanone;dodecakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 159712247), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).